Prof Bobby Gaspar, PhD, MRCP(UK), MRCPCH
Professor of Paediatrics and Immunology, UCL GOS Institute of Child Health
Bobby Gaspar is a physician/scientist working in paediatric immunology at the Institute of Child Health (ICH) and Great Ormond Street London. He initially trained in paediatrics and then became interested in primary immunodeficiencies at an early stage in his career and undertook a PhD at the Molecular Immunology Unit at ICH. From there he has continued his academic and clinical career. His interests are in many different aspects of primary immunodeficiency including understanding the molecular and cellular defects and disease pathogenesis, bone marrow transplantation for severe immunodeficiencies and the development of gene and cell therapy for these conditions. Over the last decade, his team have conducted clinical trials that have shown that gene therapy can successfully correct the immune defect in specific immunodeficiency conditions.
He is also leading UK and European initiatives for newborn screening for severe combined immunodeficiency
Bobby is co-founder and Chief Scientific Officer of Orchard Therapeutics, a biotechnology company arising from his work at UCL/GOSH that is making gene therapy medicines for severe genetic diseases